Back Refine search Reset
Please choose a search criteria from below
Filters Clear all
Specialties
Treatments

41 results found in Bloomsbury

Sort by:
Showing 1 - 10 of 41 results
Expert in: Oncology
Recommended by 1 specialist
27 years of experience
Medical Oncology

Dr Mulholland is a medical Oncologist who exclusively treats brain cancer at University College Hospital, the National Hospital for Neurology and Neurosurgery (part of UCLH) and Mount Vernon Cancer Centre.He is also an honorary senior lecturer at UCL and a training programme director. 

His doctoral research was in genomic profiling in brain cancer at Cancer Research UK - this has led to his focus on developing biomarkers and targets for therapy in brain cancer, including the clinical trial portfolio of novel agents in brain cancer which he now runs at UCLH and nationally. 

He is a clinical lead in a European Consortium called Datrix, a multidisciplinary European collaboration to advance next-generation targeted hyperthermic cancer treatment for glioblastoma.

 

 

 

Read more
Dr Rakesh Popat

Dr Rakesh Popat

0.01 miles

Dr Rakesh Popat

0.01 miles
Expert in: Haematology
22 years of experience

Dr Rakesh Popat is a Consultant Haematologist with specialist expertise in Multiple Myeloma. His NHS base is at University College Hospital, London where he leads the Myeloma Clinical Trials Program and is the Cancer Program lead for the NIHR UCLH Clinical Research Facility. He has particular experience with novel treatments including immunotherapies such as CAR-T cell therapy and new antibody approaches.

Dr Popat is on the leadership boards of the UK Myeloma Forum, The UK Myeloma Research Alliance and the European Myeloma Network. In addition, he is the Haematology lead for the North Thames Clinical Research Network. He completed a PhD in novel treatments for Myeloma and was awarded a Fellowship to attend the Dana Farber Cancer Institute, Boston USA as part of this.

Read more
Expert in: Oncology
33 years of experience

Professor John Bridgewater is a Consultant Medical Oncologist and Clinical Researcher at the UCL Cancer Institute. He specialises in gastrointestinal oncology, with a particular interest in biliary tract cancers and carcinomas of unknown primary origin.

After studying medicine at Oxford and University College London, he went on to specialise in Medical Oncology at the Middlesex, Mount Vernon and Royal Marsden Hospital. He was awarded a PhD by the Institute of Cancer Research for research into gene therapy. In 1999 he was appointed as a Senior Lecturer in Medical Oncology at UCL.

Professor Bridgewater leads the National Cancer Research Institute subgroup in hepatobiliary malignancy and also has a laboratory programme at the UCL Cancer Institute investigating carcinoma of unknown primary origin. He is also active in trials across the gastrointestinal portfolio and has been the chief investigator on a number of landmark studies into gastrointestinal and biliary tract cancers. As well as his clinical and research work, he also serves on a number of committees including The National Institute for Health and Care Excellence (NICE) and National Cancer Research Institute (NCRI). 

Read more
Expert in: Haematology
35 years of experience

Professor Kwee Lan Yong is a specialist in Haematological Oncology and one of the leading specialists in the treatment of patients with multiple myeloma.

She completed her medical training at Oxford University and University College London (UCL), before undertaking doctoral studies at UCL and was awarded a PhD in 1993 for her research into growth factors. In 1999 she was appointed as a Senior Lecturer and Honorary Consultant at UCL, before becoming Clinical and Academic Lead in Multiple Myeloma at University College Hospital and the North London Cancer Network (NLCN).


Dr Yong runs an active trials programme and a laboratory research programme. She has published more than 60 original papers in peer-reviewed journals, and is a reviewer for international journals and grant-awarding bodies. She runs the undergraduate course for Haematology at UCL Medical School and regularly speaks at international conferences.

Read more
Dr Neil Rabin

Dr Neil Rabin

0.01 miles

Dr Neil Rabin

0.01 miles
Expert in: Haematology
23 years of experience

Dr Neil Rabin is a Consultant Haematologist who works at University College Hospital. His special interests include clinical trials evaluating new treatments for myeloma at diagnosis and at relapse.

Read more
Expert in: Oncology
29 years of experience
Clinical Oncology

Dr Beatrice Seddon is consultant on the Sarcoma Unit at University College Hospital, which together with the Bone Tumour Unit at the Royal National Orthopaedic Hospital, comprises the London Bone and Soft Tissue Tumour Service.

Dr Seddon trained in treating sarcomas at the Royal Marsden and Middlesex Hospitals in London, and now specialises exclusively in the treatment of soft tissue and bone sarcomas with chemotherapy and radiotherapy.

She completed her PhD (University of London) at the Institute of Cancer Research in imaging of tumour hypoxia, and currently has a strong interest in clinical trials in sarcoma, acting as principal and chief investigator for a number of national and international trials. She is actively involved in coordinating sarcoma research at a national level as a member of the NCRN Sarcoma Clinical Studies Group, and is also a member of the EORTC Soft Tissue and Bone Sarcoma Group. She regularly teaches and lectures on the management of sarcomas.

 

 

Read more
Expert in: Haematology
24 years of experience

Dr Charalampia Kyriakou is a Consultant Haematologist at University College London Hospitals NHS Trust (UCLH), London North West University Healthcare NHS Trust (LNWH) and the Royal National Orthopaedic Hospital Myeloma Spinal Service. She also prides a first-class service with HCA Healthcare, where she helps patients suffering from multiple myeloma, lymphoma and other blood cancers. She also specialises in stem cell transplantation for multiple, lymphoma and for patients with multiple sclerosis.

She offers a holistic approach to treatments, with her patients best interest at heart at all times. She is dedicated to improving outcomes and wellbeing for her patients.

After qualifying with a Medical Degree, she completed an extensive rotational training scheme in haematology at University College London Hospital before being appointed as Consultant. Since then she has been appointed to numerous committees and teams, including the stem cell transplantation team for Myeloma at UCLH, the Myeloma Spinal Service at RNOH and is the Lead for Myeloma and Lymphoma services at LNWH.

She is heavily involved in national and international clinical trials with a passion for improving cancer outcomes. During her career, she has published over 50 peer-reviewed papers and contributed to two chapters in haematology textbooks.

Read more
Expert in: Oncology
25 years of experience

Martin graduated from the University of Newcastle upon Tyne and gained general medical experience in New Zealand, Australia and the United Kingdom, becoming a member of the Royal College of Physicians (UK) in 2000. Since then he has been working in cancer care, training in Medical Oncology at the Oxford Radcliffe and Royal Marsden NHS Trusts. During this time, he achieved a PhD at the Institute for Cancer Research, London, and was awarded the EORTC-PAMM Young Investigator Award in 2004. He completed his specialist training in Medical Oncology in 2008 and was appointed as a UCL Clinical Senior Lecturer and UCH Consultant in Medical Oncology in 2009. Since then he has been running a research-based practice and has been principal/chief investigator for more than 20 early and late phase clinical trials.

Martin is involved in the management of patients with both lung and head and neck cancers. He is interested in drug development and in using the increasing understanding of cancer biology to design studies that distinguish patient populations most likely to gain benefit from new drugs and new drug combinations. He has a particular interest in cancer biology that leads to the development of both lung and head and neck cancers.

Read more
Expert in: Oncology
16 years of experience
Medical Oncology

Dr Tobias Arkenau is a renowned Consultant Medical Oncologist with HCA Healthcare at numerous locations including Sarah Cannon Research Institute, The Harley Street Clinic, The Princess Grace and The Wellington Hospital. Additionally, he holds an NHS post at University College London Hospital where he is a Professorial Research Associate. 

He is a founding Medical Director of the Sarah Cannon Research Institute UK and is currently serving as the Executive Medical Director for SCRI UK and Clinical Lead for the HCA Healthcare UK Cancer Service Line. The talented physician has a wide range of experience in a variety of cancers, particularly gastrointestinal and skin cancers. 

He was awarded his medical degree from Hanover Medical School in Germany in 2000. Following this, he completed his specialist training in oncology across numerous centres of excellence including the Royal Marsden Hospital. He was awarded a Fellowship by the Royal College of Physicians, and he is a key opinion leader in his field of Gastrointestinal Cancers, Drug Development and Immunotherapy for his reserach contributions to his field. During his career, he has published numerous peer reviewed articals and book chapters and contributes regulalry at international meetings such as ASCO, ESMO and AACR. He is leading the Sarah Cannon Institute UK as a Chief and Principal Investigator of numerous clinical trials of new anti-cancer drugs including immunotherapies and cellular therapies.

Read more
Expert in: Haematology
39 years of experience

Professor Stephen Mackinnon is a Consultant Haematologist at HCA UK at University College Hospital. He specialises in haemato-oncology and has extensive experience in the diagnosis, management and treatment of leukaemia, myeloma and lymphoma.

He attended medical school at the University of Glasgow and then trained in internal medicine and haemato-oncology in Glasgow. He then undertook a transplant fellowship at the Hammersmith Hospital in London where he developed an interest in graft-versus-leukaemia reactions. In 1990 he moved to Memorial Sloan Kettering Cancer Center in New York to continue this work in both the clinic and the lab. His work included making the use of donor lymphocytes less toxic by limiting the T cell dose administered to transplant recipients allowing separation of graft-versus-leukaemia responses from graft-versus-host disease. In 1995 he returned to London to lead the bone marrow and stem cell program at University College London.

In recent years, Professor Mackinnon has developed an interest in novel conditioning regimens. Current research interests include adoptive immunotherapy and immune reconstitution following allogeneic stem cell transplantation, a programme which has resulted in world class transplant outcomes for patients with leukaemia and lymphoma.

  

Read more